Conclusion
This phase I/II clinical trial, performed by a single expert surgeon, demonstrated the safety and feasibility of SPRDG in selected patients. SPRDG could be a reasonable alternative to conventional or reduced-port minimally invasive gastrectomy, with cosmetic advantages, early recovery, and safe discharge.